Evidence map›Paper›PMID 36361696›Full record

ArticleInternational journal of molecular sciences2022

The Promoter Region of the Proto-Oncogene MST1R Contains the Main Features of G-Quadruplexes Formation.

Coralie Robert, Julien Marquevielle, Gilmar F Salgado

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. MST1R as a potential new target antigen of chimeric antigen receptor T cells to treat solid tumors.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Coralie RobertARNA Laboratory, Inserm U1212, CNRS UMR 5320, University of Bordeaux, 146 Rue Léo Saignat, F-33000 Bordeaux, France.
Julien MarquevielleARNA Laboratory, Inserm U1212, CNRS UMR 5320, University of Bordeaux, 146 Rue Léo Saignat, F-33000 Bordeaux, France.ORCID 0000-0001-8155-5195
Gilmar F SalgadoARNA Laboratory, Inserm U1212, CNRS UMR 5320, University of Bordeaux, 146 Rue Léo Saignat, F-33000 Bordeaux, France.ORCID 0000-0002-0296-5979
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MST1R (RON) is a receptor of the MET tyrosine kinase receptor family involved in several cancers such as pancreas, breast, ovary, colon, and stomach. Some studies have shown that overexpression of MST1R increases the migratory and invasive properties of cancer cells. The promoter region of the oncogene MST1R is enriched in guanine residues that can potentially form G-quadruplexes (G4s), as it was observed in other oncogenic promoters such as KRAS and c-MYC. There is abundant literature that links the presence of G4s in promoter regions of oncogenes to diverse gene regulation processes that are not well understood. In this work, we have studied the reverse and forward sequence of MST1R promoter region using the G4Hunter software and performed biophysical studies to characterize the best scored sequences.

Indexed as

G-QuadruplexesGuaninePromoter Regions, GeneticProto-OncogenesReceptor Protein-Tyrosine KinasesGuanineReceptor Protein-Tyrosine KinasesG-quadruplexMST1Rpromoter

Identifiers

PMID36361696
PMCPMC9653784
OpenAlexW4307552373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.